Med Student Medical News about micafungin

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected intensive care unit-acquired candidemia among patients with sepsis: a model simulation
Critical Care, 07/02/09

Zilberberg MD et al. - Recent epidemiologic literature indicates that candidal species resistant to azoles are becoming more prevalent in the face of increasing incidence of hospitalizations with candidemia. Given the increasing likelihood of azole resistance among candidal isolates, empiric treatment of ICU-AC with 100 mg daily MIC is a cost effective alternative to FLU.

<< Previous
Graves Hyperthyroidism after Stopping Immune Suppressive Therapy...

Next >>
Maturity-Onset Diabetes of the Young (MODY) in Children with...

Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants
Clinical Pharmacology & Therapeutics, 11/06/09 Relevance Score: 87%

Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
Critical Care, 10/20/09 Relevance Score: 84%

A Survival Case of ABO-Incompatible Liver Transplantation Complicated With Severe Preoperative Infection and Subsequent Overwhelming Postsplenectomy Infection
Transplantation Proceedings, 11/18/09 Relevance Score: 80%

Candidiasis: New agents for invasive infections
The Clinical Advisor, 10/06/09 Relevance Score: 77%